Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors
Park Square has placed David Pyott as Independent Director at Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel...…